SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $37,017 | +61595.0% | 24,600 | -52.6% | 0.01% | -33.3% |
Q1 2023 | $60 | -60.3% | 51,900 | +339.8% | 0.01% | -40.0% |
Q4 2022 | $151 | -99.6% | 11,800 | -7.1% | 0.02% | +650.0% |
Q2 2022 | $36,000 | -43.8% | 12,700 | -33.9% | 0.00% | -33.3% |
Q1 2022 | $64,000 | -77.1% | 19,200 | -52.5% | 0.00% | -62.5% |
Q4 2021 | $280,000 | -16.4% | 40,400 | -17.7% | 0.01% | -20.0% |
Q3 2021 | $335,000 | +544.2% | 49,100 | +187.1% | 0.01% | +400.0% |
Q2 2021 | $52,000 | -95.0% | 17,100 | -73.5% | 0.00% | -96.4% |
Q1 2021 | $1,050,000 | -63.2% | 64,582 | -3.8% | 0.06% | -31.7% |
Q4 2020 | $2,850,000 | +707.4% | 67,123 | +28.8% | 0.08% | +382.4% |
Q3 2020 | $353,000 | -64.9% | 52,100 | -14.9% | 0.02% | -69.1% |
Q2 2020 | $1,006,000 | -36.4% | 61,200 | -62.5% | 0.06% | -36.8% |
Q4 2019 | $1,583,000 | +433.0% | 163,300 | +279.8% | 0.09% | +262.5% |
Q3 2019 | $297,000 | -96.7% | 43,000 | -89.7% | 0.02% | -96.5% |
Q2 2019 | $9,045,000 | +2537.0% | 417,166 | +275.8% | 0.70% | +2141.9% |
Q1 2019 | $343,000 | -83.4% | 111,000 | +68.7% | 0.03% | -76.2% |
Q4 2018 | $2,065,000 | -46.1% | 65,794 | -7.1% | 0.13% | -46.3% |
Q3 2018 | $3,829,000 | +109.6% | 70,803 | +2.9% | 0.24% | +163.0% |
Q2 2018 | $1,827,000 | +559.6% | 68,800 | +69.0% | 0.09% | +557.1% |
Q1 2018 | $277,000 | +42.1% | 40,700 | +2.0% | 0.01% | +75.0% |
Q4 2017 | $195,000 | +84.0% | 39,900 | +59.6% | 0.01% | +60.0% |
Q3 2017 | $106,000 | -95.1% | 25,000 | -82.1% | 0.01% | -95.4% |
Q4 2016 | $2,177,000 | +36.3% | 139,356 | -50.5% | 0.11% | +94.6% |
Q3 2016 | $1,597,000 | -2.5% | 281,700 | -31.6% | 0.06% | -41.7% |
Q2 2016 | $1,638,000 | +6725.0% | 411,900 | +2906.6% | 0.10% | +4700.0% |
Q1 2016 | $24,000 | -95.3% | 13,700 | -80.4% | 0.00% | -92.0% |
Q4 2015 | $515,000 | +2929.4% | 69,800 | +571.2% | 0.02% | +2400.0% |
Q3 2015 | $17,000 | -99.1% | 10,400 | -98.0% | 0.00% | -99.1% |
Q2 2015 | $1,818,000 | +2613.4% | 510,000 | +434.0% | 0.11% | +5400.0% |
Q2 2014 | $67,000 | -85.7% | 95,500 | -6.2% | 0.00% | -86.7% |
Q4 2013 | $468,000 | -20.1% | 101,800 | +69.9% | 0.02% | -21.1% |
Q3 2013 | $586,000 | -82.6% | 59,900 | -83.1% | 0.02% | -83.3% |
Q2 2013 | $3,374,000 | – | 355,419 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |